Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study.

Morten Daniel Jensen Hugh WatsonHendrik VilstrupProf Peter Jepsen

Published in: Clinical epidemiology (2023)

NSBB use may reduce the risk of sepsis in patients with cirrhosis and ascites, but the precision of the estimate was limited by the number of episodes of sepsis.

Keyphrases

septic shock
acute kidney injury
intensive care unit
cell free
angiotensin converting enzyme